APA (7th ed.) Citation

Shan, J., Liu, Z., Chen, S., Du, C., Li, B., Ruan, L., . . . Tu, Z. (2024, June). Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: Promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy. BMC Medicine.

Chicago Style (17th ed.) Citation

Shan, Jianzhen, et al. "Optimizing Perioperative Treatment for Potentially Resectable Stage III Squamous Cell Lung Carcinoma: Promising Results of a Condensed Four-cycle Regimen with Tislelizumaband Chemotherapy." BMC Medicine Jun. 2024.

MLA (9th ed.) Citation

Shan, Jianzhen, et al. "Optimizing Perioperative Treatment for Potentially Resectable Stage III Squamous Cell Lung Carcinoma: Promising Results of a Condensed Four-cycle Regimen with Tislelizumaband Chemotherapy." BMC Medicine, Jun. 2024.